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Abstract: 
Introduction: Acute unilateral leg swelling and/or pain is one of the most common complaints to be encountered in 
an emergency department (ED). The prompt responses is devoted to adequately Diagnose or eliminate the critical 
causes. Deep vein thrombosis has a high incidence as of 1 per 1000 person-year. When it comes to an emergency 
department, it has been estimated that about 10-25 percent of suspected cases would turn out to have a DVT. The 
concern of the presence of IC-DVT has emerged from the risk of thrombus propagation. Hence, development of A 
proximal DVT. This in turn, as stated earlier, has a higher risk of complication with pulmonary embolism or post-
thrombotic syndrome. 
Aim of work: In this review, we will discuss the recent available evidence regarding the management of DVT. 
Methodology: We performed a systematic search for the management of deep venous thrombosis. The PubMed 
search engine (http://www.ncbi.nlm.nih.gov/) and Google Scholar search engine (https://scholar.google.com) were 
the main search engine that has been used. We also included in our search the recent advancement and guidelines 
regarding the management of deep venous thrombosis. 
Conclusions: Unilateral leg pain and/or swelling is a common ED complaint. The diagnosis of isolated calf vein 
DVT is particularly challenging when the Standard diagnostic modality, a whole-leg ultrasound WLUS, is not 
readily available. Treatment is controversial, universal versus selective anticoagulation. The risks of proximal 
progression and life-threatening embolization should be considered along the benign nature of a distal clot. An 
individual patient risk factors for both clot propagation and the complications of therapy should also be considered. 
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Acute unilateral leg swelling and/or pain is one of the 
most common complaints to be encountered in an 
emergency department (ED). The prompt responses 
are devoted to adequately Diagnose or eliminate the 
critical causes.  Deep vein thrombosis (DVT) is 
usually one of the first causes that should be 
investigated. This is especially important with the 
proximal type of DVT, which carries a high risk of 
pulmonary embolism and its complications. Despite 
the exclusion of proximal DVT usually takes a place 
early, the isolated calf Deep Vein Thrombosis (IC-
DVT) often remains in the list of differential 
diagnosis. This is attributed to the lack of Whole-leg 
duplex ultrasonography (WLUS) in the majority of 
ED, The gold standard to yield the diagnosis. This 
paucity of WLUS leads to postponement of the 
diagnosis for several hours. 
 
Deep vein thrombosis has a high incidence as of 1 
per 1000 person-year. When it comes to an 
emergency department, it has been estimated that 
about 10-25 percent of suspected cases would turn 
out to have a DVT. The isolated calf DVT was found 
to be in 11 percent of 1495 individuals had been 
suspected to have it in a community-based study [1].  
After performing a Whole-leg duplex 
ultrasonography (WLUS), this percent went as high 
as 50 percent [2]. The concern of the presence of IC-
DVT has emerged from the risk of thrombus 
propagation. Hence, development of A proximal 
DVT. This in turn, as stated earlier, has a higher risk 
of complication with pulmonary embolism or post-
thrombotic syndrome. Thus, although these types of 
DVT differ in the carried risk on a short-term basis, 
the long-term outcomes are similar between them. 
 
We aim in this review to discuss the recent available 
evidence regarding the management of DVT. In 
addition, we propose an algorithm for the evaluation 
of a patient with suspected IC-DVT in the lack of a 
Whole-leg duplex ultrasonography, and the treatment 
controversy of this entity. 
 
METHODOLOGY: 
We performed a systematic search for the 
management of deep venous thrombosis. The 
PubMed search engine 
(http://www.ncbi.nlm.nih.gov/) and Google Scholar 
search engine (https://scholar.google.com) were the 
main search engine that has been used. We also 
included in our search the recent advancement and 
guidelines regarding the management of deep venous 
thrombosis. All relevant studies were retrieved and 
discussed. We only have included the full articles 
available. 
The key terms have been used in our search are Deep 
venous thrombosis, management, surgery, and 
emergency. 
 
The Risk of propagation, pulmonary embolism 
and the mortality in the isolated calf DVT. 
It has been assumed that the vast majority of DVT, 
including the proximal types, were started in the calf 
veins, i.e. more distal. Then, it propagates to more 
proximal veins such as popliteal or femoral veins for 
instance. This propagation from untreated, 
symptomatic calf thrombus is found to be happening 
in about 16% of the time [3,4]. Yet, the propagation 
has not been encountered after the period of two 
weeks [5]. The risk factor favors this extension 
varies. The positive D-dimer, the presence of 
malignancy or history of it, a previous 
thromboembolic event, the large size of the thrombus 
and its closeness to proximal veins in addition to 
prior trauma. In addition to lack of the reversible 
provoking factors, all of these are associated with 
higher incidence of propagation. 
 
Although it is common, the mortality of IC-DVT is 
still rare and was accounted to be less than 1%. 
However, the association between the benign IC-
DVT and more serious complications as pulmonary 
embolism is being investigated. It was found that 
when the search of DVT was begun after the 
diagnosis of PE had been made, about 10% of cases 
turned to have IC-DVT. 18 From the other hand, 13% 
of patient with IC-DVT would have asymptomatic 
PE if they tested.18 This relation is currently 
undergoing active discussion, and will not be 
addressed in this review [6,7]. 
 
How Should the Diagnosis of Suspected IC-DVT 
Be Approached?  
The approach to suspected IC-DVT is best to be done 
by using the Whole-leg duplex ultrasonography 
(WLUS). When WLUS rules out the IC-DVT, The 
risk of subsequent composition of venous 
thromboembolism (VTE) complication is less than 
1% [8].   When  WLUS is not readily available, the 
alternative modalities to be used are the proximal 
compression ultrasonography –whether bedside or at 
radiology department, the  clinical probability 
assessments, and the D-dimer status. 
 
Combining the Clinical probability (Wells Score) and 
D-dimer test could be helpful. In low-risk patients 
(Wells score of 0 or less), the D-dimer test has a high 
negative predictive value that has been estimated to 
be as high as 99% or more [9]. This is true for DVT 
in general, as well as IC-DVT. The Clinical Practice 
Guidelines for Antithrombotic Therapy and 
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prevention of thrombosis published in 2012 by 
American College of Chest Physicians (ACCP) 
endorsed the combination of these two methods in 
ruling out DVT of the lower extremity. Hence, when 
the D-dimer is negative and the pretest probability 
(using Wells score) is low, there is no benefit from 
further testing. This is supported by Wells et al. 2003, 
2006 and ACCP 2012 guideline. However, when the 
D-dimer is positive, the ACCP guideline 
recommends the using of proximal compression 
ultrasound. 
 
In the absence of WLUS, and The presence of 
positive D-dimer or moderate to a high probability 
using the Wells score, prompt the use of compression 
Ultrasound (CUS) in the emergency department to 
rule out proximal DVT. A positive test by CUS 
would recognize the need for therapeutic 
anticoagulation. The significant increase in trained 
ED physicians to utilize the CUS made this modality 
more accessible in the bedside rather than the need 
for radiological studies. This is especially important 
after the end of ordinary working hours.  
 
The sensitivity of bedside CUS has been assessed by 
multiple studies, it was estimated to be about 95 – 99 
percent.10-11 Nevertheless, The classical CUS remains 
an option in case it is available. When combining the 
negative D-dimer result with a bedside CUS, the 
modality is adequately effective in excluding the vast 
majority of clinically important DVT, with estimated 
NPV to be more than 99%. This alternative is 
particularly important in patients with moderate to 
high pretest probability. 
 
IC-DVT in the Setting of Positive D-dimer and 
Negative CUS for Proximal DVT. 
WLUS remains the definitive diagnostic test when 
the D-dimer resulted to be positive and CUS is 
negative. When WLUS is deficient and not readily 
available, the ACCP guideline recommends two 
alternative strategies (presented in the Figure). The 
first is a direct imaging of the calf veins using a 
short-term definitive whole-leg ultrasound. From the 
other hand, repeating the proximal CUS after one 
week to assess proximal progression could be an 
alternative.5 This repetition of CUS after a single 
week has been found to be equivalent to a single 
WLUS in excluding IC-DVT that carries the 
likelihood of progression. Furthermore, it is safe (0-
1.8% VTE at 3-6 months) [12]. This would aid the 
ED patients whom the routine follow up as an 
outpatient is not reliable for any reason. Now, 
returning to ED to repeat bedside CUS would be an 
option. 
 
After excluding proximal DVT in the ED and the 
possibility of IC-DVT is being investigated either by 
planned short-term deferred WLUS or repeated 
proximal CUS, the practice of providing a bridge of 
empiric anticoagulation between imaging studies is 
not supported [13,14]. 
 
Treatment of Confirmed IC-DVT - Selective 
Anticoagulation. 
After presenting a suggested algorithm for the 
diagnosis of IC-DVT in lack of immediate WLUS. 
We will briefly review the controversy about IC-
DVT treatment [15,16]. The previously mentioned 
ACCP guidelines, the current European guidelines, 
and the currently available evidence all of which 
have recommended treating IC-DVT with at least 
three months of anticoagulation [17,18].  The latest 
ACCP guidelines include a more selective approach. 
The controversy regarding the different approaches is 
best exemplified by a survey of faculty physicians in 
one of major U.S medical center. Half of the 
respondents chose the “routinely use anticoagulation 
to treat venous thrombosis below the knee” and half 
did not [19]. This controversy over treatment 
approaches is largely derived from the increased 
frequency of diagnosed IC-DVT, coupled with the 
belief that the distal DVT is less concerning than 
proximal. In addition, the risk factors associated with 
it are more likely to be transient and reversible. 
Nevertheless, the mortality and recurrence rates are 
scanty.20 Physicians who prefer the observation 
strategy over the treatment approach argue to support 
their decision by the fact that the majority of patients 
with negative proximal DVT by CUS –even if they 
have missed IC-DVT- would have an acceptable 
outcome without treatment.  These accepted 
outcomes outweigh the possible complication by 
treatment approach as a bleeding for an example. As 
the case of our patient.  
 
There is a universal demand for a large randomized 
trial to address this question. In response to this 
critical question, a promising trial is currently 
ongoing (www.ClinicalTrials.gov) [21]. Until now, in 
the absence of a definitive answer, recommendation, 
as suggested by the ACCP, to base the treatment 
decision on risks/benefits analysis and shared 
decision-making is widely used. 
 
Treatment of Confirmed IC-DVT - Shared 
Decision-Making.  
The ACCP Current guideline based on the best 
available evidence (currently in their 10th edition, 
spanning 30 years) has suggested a solid point for the 
clinical decision-making process [22] the latest 
edition has proposed two options to deal with 
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confirmed IC-DVT: The first of which is the use of 
therapeutic anticoagulation; the second is a weekly-
based follow-up with compression ultrasonography 
(CUS) for two weeks to monitor proximal thrombus 
propagation. The use of anticoagulation is reserved 
for severely symptomatic patients and/or those with 
higher risk factors for proximal extension should. 
Patients who are carrying a high risk of 
anticoagulation-associated major bleeding may be 
managed by follow up. In Contrast, patients with a 
lower risk of both propagation and hemorrhage may 
greatly benefit a more selective approach using 
shared decision-making [23]. The discussion should 
be well documented and focuses on the patient’s 
judgment and readiness to comply with serial 
surveillance for clot propagation versus their 
tolerance for the risks of bleeding associated with the 
medication. Given the controversy over IC-DVT 
management, a primary provider and/or a consultant 
should be involved in the decision-making whenever 
it is possible. In addition to their effort to assure a 
close follow up. There is a lack of data regarding 
either strategy for IC-DVT in patients with a variable 
level of risks.  
 
Additional therapeutic modality.  
There is no evidence regarding the use of gradual 
compression stocking neither for symptomatic relief 
nor for its role in preventing post-thrombotic 
syndrome (PTS) in the cases of IC-DVT. However, 
regarding the proximal DVT, the reported adverse 
events from using these stockings are rare, and their 
value for PTS preventions is uncertain [24,25]. No 
recommendations could be found for the role of 
aspirin in the management of IC-DVT. 
 
Surgical interventions: Pulmonary embolectomy 
and IVC filters. 
Pulmonary embolectomy.  
The ACCP guideline suggests an initial management 
of PE by surgical pulmonary embolectomy only in 
massive cases, which should be documented by 
angiography whenever it is possible. This massive PE 
includes the failure of heparin and resuscitation 
efforts, thrombolytic therapy or a contraindication to 
its use. To date, no randomized trials evaluating this 
have been found. Stein et al. Pooled data has shown 
about 20% of mortality rate related to operation in 
patients undergoing pulmonary embolectomy 
between 1985 and 2005, compared with 32% before 
1985.29 A more recent retrospective study included a 
214 patients undergoing surgical embolectomy for 
massive and submassive PE has found in-hospital 
mortality rate  to be 11.7%. The highest death rate 
was (32.1%) in patients with preoperative cardiac 
arrest. Surgical embolectomy in patients with 
intermediate to high-risk conditions (defined as 
elevated biomarkers and evidence of right heart strain 
on computed tomographic angiography or 
echocardiography) has also been reported [26]. 
 
IVC filters.  
Current recommendation precludes the routine use of 
IVC filters for patients with DVT or PE who are 
suitable for management with anticoagulants. 
However, in the presence of contraindication to 
anticoagulant, complications of its usage, recurrent 
thromboembolism events despite adequate 
anticoagulant therapy, and the use of IVC become 
absolute indications. Nevertheless, the relative 
indications for IVC filters include massive PE; 
iliocaval DVT; free-floating proximal DVT; cardiac 
or pulmonary insufficiency; a high risk of 
complications from anticoagulation (frequent falls, 
ataxia); and poor compliance to the treatment. 
 
When the anticoagulant is temporary contraindicated 
or in case of a short duration of PE risk, the 
retrievable IVC filter is an adequate consideration.27 
The consensus guidelines advise the same indications 
for placing a retrievable IVC filter as well as a 
permanent device.  The IVC filter by itself is not an 
effective therapy for VTE, and resumption of 
anticoagulation is recommended as soon as possible 
after its placement. 
 
SCREENING AND PREVENTION 
More than half of all VTE events occur in hospitals 
and nursing homes [28]. Yet,te use of anticoagulant 
prophylaxis greatly differed among hospitalized 
patients for medical conditions versus a hospitalized 
patients for surgical one. The estimated percent of at-
risk patients who have been managed by 
anticoagulant was 16 to 33 among the medical 
hospitalized versus a 90% of surgical [29] a meta-
analysis involving 19,958 patients has showed that 
Adequate prophylaxis can reduce the incidence of 
VTE., with a Relative Risk reduction of 64% of fatal 
PE, 58% for symptomatic PE, and a 53% reduction 
for a symptomatic DVT 
 
The consequences of VTE include symptomatic DVT 
and PE whether fatal or symptomatic, the cost of 
investigating symptomatic patients, the risk and cost 
of treatment (e.g. bleeding), PTS, and chronic 
thromboembolic pulmonary hypertension.  
 
Heparin, enoxaparin, and fondaparinux are approved 
drugs for prophylaxis use. However, the indication of 
these drugs varies. Foe example, factor Xa inhibitors, 
rivaroxaban, and apixaban were approved for 
prophylaxis in patients undergoing total knee or hip 









Recently, the factor Xa inhibitor, betrixaban, has 
been approved for VTE prophylaxis up to 42 days in 
a hospitalized adult suffering an acute medical 
illness.44 patients with a high risk of bleeding who 
are unable to receive pharmacologic prophylaxis, 
intermittent pneumatic compression devices or 




In patients with DVT, ACCP guideline advises 
against the routine use of compression stockings as 
preventive measure. While the current evidence 
suggests that compression stockings is not effective 
measure for PTS prevention, they may reduce the 
symptoms of acute or chronic DVT in some patients. 
 
LIMITATIONS  
The significant variation in overall and subset types 
of DVT is a major drawback. Despite the large 
number of available reports, many of them are 
derived from small underpowered observational 
cohort studied. A Subsequent meta-analysis has tried 
to combine the data of these studies. The plausible 
explanations of this observed variability include the 
size and heterogeneity of the patient sample. Whether 
they were inpatient, outpatient, community-based 
sample, post-surgical, traumatic, presence or absence 
of symptoms, the reason for testing (suspected or 
confirmed PE, versus DVT), and the diagnostic 
imaging modality had been used. Most series did not 
image the entire leg.  
 
Another limitation is the fact that the suggested 
algorithm was based on the latest evidence and 
practice guidelines. When the literature is rich in 
papers discussing this topic, the lack of prospective 
controlled evaluation makes the current evidence of 
low quality. A prospective controlled trial would be 
essential. 
 
The loss of follow up in almost all the strategies 
concerned about surveillance approaches is an 
important factor to be considered.  During the period 
covered by this discussion, D-dimer assays evolved 
and the Wells clinical prediction rules were modified.  
The current recommendations are based on the use of 
highly sensitive D-dimer assay. there is a  variable 
types of  assays in the practical situation.58  Both the 
Wells criteria and D-dimer assays have greater 
sensitivity for proximal than isolated distal DVT 
[30]. 
Leg pain and swelling are among the common ED 
complaints that trigger a search for serious conditions 
requiring urgent intervention. Yet, less than 25% of 
these patients would have DVT. Even after applying 
the clinical decision rules and performing the 
diagnostic tests with a high sensitivity as well as 99 
percent, the physicians would encounter a false 
negative with serious consequences. The literature is 
rich in many cases as an example of this [31].     
 
CONCLUSION:  
Unilateral leg pain and/or swelling is a common ED 
complaint. The diagnosis of isolated calf vein DVT is 
particularly challenging when the Standard diagnostic 
modality, a whole-leg ultrasound WLUS, is not 
readily available. A proposed diagnostic algorithm to 
be used in the ED is presented. The algorithm has 
been based on the most recent recommendations of 
the American College of Chest Physicians (ACCP). It 
is important to carry in mind that this algorithm is 
based on a critical appraisal of the current evidence in 
the literature. The current evidence lacks the adequate 
strength, and prospective controlled studies still 
required before it can be recommended for a 
widespread implementation. Treatment is 
controversial, universal versus selective 
anticoagulation. The risks of proximal progression 
and life-threatening embolization should be 
considered along the benign nature of a distal clots. 
Individual patient risk factors for both clot 
propagation and the complications of therapy should 
also be considered. 
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